<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The evaluation of TLR1, TLR2, TLR4, TLR7, and TLR8 expression levels in the newly-diagnosed acute myeloid leukemia (AML) patients</title>
	<subject_fa>Adults Hematology &amp; Oncology</subject_fa>
	<subject>Adults Hematology &amp; Oncology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;line-height:2;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Arial;&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;letter-spacing:-.5pt&quot;&gt;Background:&lt;/span&gt;&lt;/span&gt;&amp;nbsp;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt;Acute myeloid leukemia (AML) is described by the clonal expansion of myeloid blasts with abnormal differentiation. Considering the role of Toll-like receptors (TLRs) in inflammation induction and the effect of chronic inflammation on cancer development, investigating the state of TLRs&amp;rsquo; expression in human malignancies has attracted scientists&amp;rsquo; attention.&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,serif&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;letter-spacing:-.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;/span&gt;&amp;nbsp;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;In this study, 36 newly-diagnosed AML patients and 36 control samples were examined. The mRNA expression levels of TLR1/2/4/7/8 were measured in both groups using real-time PCR. The student&amp;rsquo;s t-test was utilized to compare gene expression levels between the two populations and the one-way ANOVA test was used to compare data among multiple subtypes. &lt;span style=&quot;color:#0e101a&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;letter-spacing:-.5pt&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;All TLR gene expression levels were significantly up-regulated in patients compared to the control group (p&lt;0.05). Positive correlations between different TLRs were observed as well.&amp;nbsp;AML patients under the age of 55 showed significantly higher TLR1/2/4 expression in comparison with healthy individuals of the same age; a similar comparison in people above 55 also showed an elevated expression of TLR1/2/4/8. Male patients overexpressed almost all genes compared to healthy subjects; the levels of TLR1/2/4 were also higher in female patients. No difference was observed comparing blast percentages and FAB subtypes.&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;letter-spacing:-.5pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&amp;nbsp;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;By considering the results of this experiment, it seems that TLRs up-regulation in AML patients may contribute to the pathogenesis and development of the disease; however, more investigations are required to elucidate the exact roles of these receptors in AML.&lt;/span&gt;&amp;nbsp;&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,serif&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;br&gt;
&lt;a href=&quot;./files/site1/files/Supplementary_Fig._1.docx&quot;&gt;./files/site1/files/Supplementary_Fig._1.docx&amp;nbsp;&lt;/a&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Acute myeloid leukemia (AML), Toll-like receptor (TLR), Gene expression, Pathogenesis, Inflammation</keyword>
	<start_page>95</start_page>
	<end_page>103</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-937-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Kosar</first_name>
	<middle_name></middle_name>
	<last_name>Fateh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>k.v.fateh@gmail.com</email>
	<code>10031947532846008899</code>
	<orcid>10031947532846008899</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Bahareh</first_name>
	<middle_name></middle_name>
	<last_name>Kashani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>bahareh_kashani@yahoo.com</email>
	<code>10031947532846008900</code>
	<orcid>10031947532846008900</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Hasanpour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zahrahasanpoor56@yahoo.com</email>
	<code>10031947532846008901</code>
	<orcid>10031947532846008901</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Naser</first_name>
	<middle_name></middle_name>
	<last_name>Shagerdi Esmaeli</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>naser.shagerdi.esmaeli@gmail.com</email>
	<code>10031947532846008902</code>
	<orcid>10031947532846008902</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vahid</first_name>
	<middle_name></middle_name>
	<last_name>Amiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>vahid.amiri529@gmail.com</email>
	<code>10031947532846008903</code>
	<orcid>10031947532846008903</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed H.</first_name>
	<middle_name></middle_name>
	<last_name>Ghaffari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>غفاری</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shghaffari200@yahoo.com</email>
	<code>10031947532846008904</code>
	<orcid>10031947532846008904</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Davood</first_name>
	<middle_name></middle_name>
	<last_name>Bashash</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>david_5980@yahoo.com</email>
	<code>10031947532846008905</code>
	<orcid>10031947532846008905</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
